SQUIRE PATTON BOGGS for BAXTER HEALTHCARE CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug and biological product pricing and reimbursement; Medical product safety; Prescription drug pedigree and anti-counterfeiting policy; Drug and device marketing and promotion; Healthcare-acquired infections; H.R. 5629, Pathway for Biosimilars Act; Implementation of P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007; Comparative effectiveness research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRET KOPLOW | — |
Medicare/Medicaid MMM
Drug and biological product pricing and reimbursement; Medical product safety; Prescription drug pedigree and anti-counterfeiting policy; Drug and device marketing and promotion; Healthcare-acquired infections; H.R. 5629, Pathway for Biosimilars Act; Implementation of P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007; Comparative effectiveness research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRET KOPLOW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.